Related Experiment Video
Updated: Jun 23, 2026

Deacetylation Assays to Unravel the Interplay between Sirtuins (SIRT2) and Specific Protein-substrates
Published on: February 27, 2016
A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9
Yuji Nakamaru1, Chaitanya Vuppusetty, Hiroo Wada
1Airway Disease Section, National Heart and Lung Institute, Imperial College, London, UK.
Abstract:
Inappropriate elevation of matrix metalloproteinase-9 (MMP9) is reported to be involved in the pathogenesis of chronic obstructive pulmonary disease (COPD). The object of this study was to identify the molecular mechanism underlying this increase of MMP9 expression, and here we show that oxidative stress-dependent reduction of a protein deacetylase, SIRT1, known as a putative antiaging enzyme, causes elevation of MMP9 expression. A sirtuin inhibitor, splitomycin, and SIRT1 knockdown by RNA interference led an increase in MMP9 expression in human monocytic U937 cells and in primary sputum macrophages, which was detected by RT-PCR, Western blot, activity assay, and zymography. In fact, the SIRT1 level was significantly decreased in peripheral lungs of patients with COPD, and this increase was inversely correlated with MMP9 expression and MMP9 promoter activation detected by a chromatin immunoprecipitation assay. H(2)O(2) reduced SIRT1 expression and activity in U937 cells; furthermore, cigarette smoke exposure also caused reduction of SIRT1 expression in lung tissue of A/J mice, with concomitant elevation of MMP9. Intranasal treatment of a selective and novel SIRT1 small molecule activator, SRT2172, blocked the increase of MMP9 expression in the lung as well as pulmonary neutrophilia and the reduction in exercise tolerance. Thus, SIRT1 is a negative regulator of MMP9 expression, and SIRT1 activation is implicated as a novel therapeutic approach to treating chronic inflammatory diseases, in which MMP9 is abundant.
Insights
Reduced SIRT1 (a protein deacetylase) levels increase MMP9 expression, contributing to chronic obstructive pulmonary disease (COPD) pathogenesis. SIRT1 activation may offer a novel therapeutic strategy for inflammatory diseases.
Area of Science:
- Molecular Biology
- Cell Biology
- Pulmonary Medicine
Background:
- Matrix metalloproteinase-9 (MMP9) elevation is implicated in chronic obstructive pulmonary disease (COPD) pathogenesis.
- The precise molecular mechanisms driving increased MMP9 expression in COPD remain incompletely understood.
Purpose of the Study:
- To elucidate the molecular mechanism responsible for elevated MMP9 expression.
- To investigate the role of SIRT1 in regulating MMP9 expression in the context of oxidative stress and COPD.
Main Methods:
- Utilized human monocytic U937 cells and primary sputum macrophages.
- Employed techniques including RT-PCR, Western blot, activity assays, and zymography.
- Investigated SIRT1 and MMP9 levels in lung tissues from COPD patients and mice exposed to cigarette smoke.
Main Results:
- SIRT1 inhibition or knockdown increased MMP9 expression, while SIRT1 activation by SRT2172 reduced MMP9 levels.
- SIRT1 levels were decreased in COPD lungs, inversely correlating with MMP9 expression and promoter activation.
- Oxidative stress (H2O2) and cigarette smoke reduced SIRT1 expression and activity, leading to elevated MMP9.
Conclusions:
- SIRT1 acts as a negative regulator of MMP9 expression.
- SIRT1 activation represents a potential therapeutic avenue for treating inflammatory conditions characterized by high MMP9 levels, such as COPD.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
TGF - β Signaling Pathway
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulation of the Unfolded Protein Response
PI3K/mTOR/AKT Signaling Pathway